Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Director's Dealing 2021

Nov 23, 2021

2543_rns_2021-11-23_95f92b95-082e-497b-82e8-f64b77bc9ab3.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014

"Sopharma" AD (the "Company") announces that it was notified by "Telso" AD related to Vessela Stoeva, that "Telso" AD executed the following transactions related to shares in the Company:

Date and time
of the
transaction
Operation Number of
rights
Unit price
(BGN)
22.11.2021 Acquired rights 280 0,01
for warrants issue
22.11.2021 Acquired rights 500 0,01
for warrants issue
22.11.2021 Acquired rights 3 086 0,01
for warrants issue
22.11.2021 Acquired rights 35 000 0,01
for warrants issue
22.11.2021 Acquired rights 100 000 0,01
for warrants issue
22.11.2021 Acquired rights 4 688 0,01
for warrants issue
22.11.2021 Acquired rights 195 450 0,01
for warrants issue
22.11.2021 Acquired rights 704 0,01
for warrants issue
22.11.2021 Acquired rights 393 399 0,01
for warrants issue
22.11.2021 Acquired rights 5 256 0,01
for warrants issue
22.11.2021 Acquired rights 4 425 0,01
for warrants issue
22.11.2021 Acquired rights 2 650 0,01
for warrants issue
22.11.2021 Acquired rights 227 0,01
for warrants issue
22.11.2021 Acquired rights 6 600 0,01
for warrants issue

The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.

Signatures of individuals authorized to represent the Company:

Ognian Donev